Eris Lifesciences Limited
HDFC Mutual Fund decreased its stake in Eris Lifesciences from 8.46% to 8.33% by selling 1,81,030 shares.
A pharmaceutical manufacturer and marketer, ERIS Lifesciences produces branded and generic drugs across multiple therapeutic areas including cardiovascular, gastroenterology, and anti-infective segments. The company operates manufacturing facilities and distributes medications through established distribution networks to serve both domestic and international markets. It focuses on developing and delivering cost-effective pharmaceutical formulations for diverse patient populations.
One of India's oldest and most trusted AMCs with over Rs 7.5 lakh crore in AUM. Founded in 1999 as a joint venture between HDFC Bank and Standard Life. MD and CEO Navneet Munot, formerly CIO of SBI MF, has reinforced the quality and compounding philosophy across equity schemes. HDFC Flexi Cap Fund and HDFC Mid-Cap Opportunities Fund are among the largest actively managed equity schemes in India.